Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow Reinvestment Rate
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Reinvestment Rate of 1.47x as of September 2025, reinvesting CN¥414.56 Million (capex CN¥414.56 Million ) from operating cash flow of CN¥282.81 Million. See 600521 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see Zhejiang Huahai Pharmaceutical Co Ltd (600521) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhejiang Huahai Pharmaceutical Co Ltd. See 600521 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.05 Billion | CN¥1.23 Billion | CN¥1.97 Billion | ▲ +88.5% |
| 2024 | 0.89x | CN¥1.93 Billion | CN¥2.17 Billion | CN¥1.85 Billion | ▼ -38.9% |
| 2023 | 1.45x | CN¥3.22 Billion | CN¥2.22 Billion | CN¥1.59 Billion | ▼ -62.1% |
| 2022 | 3.82x | CN¥4.75 Billion | CN¥1.24 Billion | CN¥2.32 Billion | ▲ +43.9% |
| 2021 | 2.66x | CN¥2.49 Billion | CN¥938.43 Million | CN¥2.43 Billion | ▲ +197.2% |
| 2020 | 0.89x | CN¥1.39 Billion | CN¥1.56 Billion | CN¥1.28 Billion | ▲ +95.6% |
| 2019 | 0.46x | CN¥801.28 Million | CN¥1.75 Billion | CN¥794.31 Million | ▼ -97.5% |
| 2018 | 18.56x | CN¥1.26 Billion | CN¥67.90 Million | CN¥1.12 Billion | ▲ +787.1% |
| 2017 | 2.09x | CN¥1.14 Billion | CN¥546.24 Million | CN¥794.54 Million | ▲ +21.5% |
| 2016 | 1.72x | CN¥746.05 Million | CN¥433.10 Million | CN¥732.88 Million | ▼ -52.3% |
| 2015 | 3.61x | CN¥705.17 Million | CN¥195.31 Million | CN¥524.28 Million | ▲ +171.5% |
| 2014 | 1.33x | CN¥437.06 Million | CN¥328.61 Million | CN¥437.06 Million | ▲ +39.9% |
| 2013 | 0.95x | CN¥466.24 Million | CN¥490.29 Million | CN¥466.24 Million | ▼ -48.2% |
| 2012 | 1.84x | CN¥447.81 Million | CN¥243.83 Million | CN¥447.81 Million | ▲ +4.8% |
| 2011 | 1.75x | CN¥346.06 Million | CN¥197.51 Million | CN¥346.06 Million | ▲ +92.6% |
| 2010 | 0.91x | CN¥272.44 Million | CN¥299.47 Million | CN¥272.44 Million | ▲ +120.8% |
| 2009 | 0.41x | CN¥130.81 Million | CN¥317.44 Million | CN¥130.81 Million | ▼ -75.0% |
| 2008 | 1.65x | CN¥138.89 Million | CN¥84.20 Million | CN¥138.89 Million | ▲ +86.8% |
| 2007 | 0.88x | CN¥120.54 Million | CN¥136.52 Million | CN¥120.54 Million | ▼ -50.5% |
| 2006 | 1.78x | CN¥138.27 Million | CN¥77.54 Million | CN¥138.27 Million | ▼ -61.9% |
| 2005 | 4.67x | CN¥249.14 Million | CN¥53.30 Million | CN¥249.14 Million | ▲ +540.6% |
| 2004 | 0.73x | CN¥119.47 Million | CN¥163.73 Million | CN¥119.47 Million | ▼ -26.6% |
| 2003 | 0.99x | CN¥47.13 Million | CN¥47.41 Million | CN¥47.13 Million | ▲ +54.1% |
| 2002 | 0.65x | CN¥48.60 Million | CN¥75.34 Million | CN¥48.60 Million | ▼ -33.1% |
| 2001 | 0.96x | CN¥36.14 Million | CN¥37.51 Million | CN¥36.14 Million | — |